 |
Articles: Drug Trials |
Prior Articles
Primary Endpoint Achieved in Phase III Clinical Trial of Epogin in Chemotherapy Induced Anemia
Chugai Pharmaceutical Co., 07/17/09
Free full text
Genmab announces lift of zalutumumab partial clinical hold
Genmab, 07/17/09
Free full text
Injectable hyaluronan for the treatment of carpometacarpal osteoarthritis: Open label pilot trial
Current Medical Research and Opinion, 07/16/09 Medtronic Clinical Trial Evaluating the Industry's First Cryoballoon Technology Designed for Paroxysmal Atrial Fibrillation Completes Follow Up
Medtronic, 07/16/09
Free full text
Primary Endpoint Achieved in Phase III Clinical Trial of Epogin in Chemotherapy Induced Anemia
Chugai Pharmaceutical Co., 07/16/09
Free full text
Primary Endpoint Achieved in Phase III Clinical Trial of Epogin in Chemotherapy Induced Anemia
Chugai Pharmaceutical Co., 07/15/09
Free full text
Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia
Current Medical Research and Opinion, 07/15/09 New Data from Phase III Saturn Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Genentech, 07/14/09
Free full text
Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome
BioMarin, 07/14/09
Free full text
Array BioPharma Announces Top-Line Results in Two Phase 1 Clinical Trials
Array BioPharma, 07/13/09
Free full text
Primary Endpoint Achieved in Phase III Clinical Trial of Epogin in Chemotherapy Induced Anemia
Chugai Pharmaceutical Co., 07/13/09
Free full text
Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity
Amylin Pharmaceuticals, 07/10/09
Free full text
Array BioPharma Announces Top-Line Results in Two Phase 1 Clinical Trials
Array BioPharma, 07/09/09
Free full text
Primary Endpoint Achieved in Phase III Clinical Trial of Epogin in Chemotherapy Induced Anemia
Chugai Pharmaceutical Co., 07/09/09
Free full text
Successful phase II/III trial of new therapy for adrenal insufficiency
b3c newswire, 07/09/09 Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
b3c newswire, 07/09/09 Allos Therapeutics Completes Enrollment in Randomized Phase 2b Trial of Pralatrexate in Patients with Advanced Non-Small Cell Lung Cancer
Allos Therapeutics, 07/08/09
Free full text
Responses After Completion of Therapy Increase Pixantrone CR/CRu Rate to 24% and ORR to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial
Cell Therapeutics, 07/08/09
Free full text
Primary Endpoint Achieved in Phase III Clinical Trial of Epogin in Chemotherapy Induced Anemia
Chugai Pharmaceutical Co., 07/08/09
Free full text
Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
Amgen, 07/08/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
